000			02182 a2200613 4500
005			20250516032854.0
264		0	_c20110809
008			201108s 0 0 eng d
022			_a1469-7793
024	7		_a10.1113/jphysiol.2010.203935 _2doi
040			_aNLM _beng _cNLM
100	1		_aHolowatz, Lacy A
245	0	0	_aOral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humans. _h[electronic resource]
260			_bThe Journal of physiology _cApr 2011
300			_a2093-103 p. _bdigital
500			_aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAnalysis of Variance
650	0	4	_aArginase _xantagonists & inhibitors
650	0	4	_aArginine _xmetabolism
650	0	4	_aAtorvastatin
650	0	4	_aBiomarkers _xblood
650	0	4	_aBiopsy
650	0	4	_aBlood Flow Velocity
650	0	4	_aCholesterol _xblood
650	0	4	_aDown-Regulation
650	0	4	_aEnzyme Inhibitors _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHeptanoic Acids _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage
650	0	4	_aHypercholesterolemia _xblood
650	0	4	_aLipoproteins, LDL _xblood
650	0	4	_aMale
650	0	4	_aMicrocirculation _xdrug effects
650	0	4	_aMicrodialysis
650	0	4	_aMiddle Aged
650	0	4	_aNitric Oxide _xmetabolism
650	0	4	_aNitric Oxide Synthase Type III _xantagonists & inhibitors
650	0	4	_aPennsylvania
650	0	4	_aPyrroles _xadministration & dosage
650	0	4	_aRegional Blood Flow
650	0	4	_aSkin _xblood supply
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aTriglycerides _xblood
700	1		_aSanthanam, Lakshmi
700	1		_aWebb, Alanah
700	1		_aBerkowitz, Dan E
700	1		_aKenney, W Larry
773	0		_tThe Journal of physiology _gvol. 589 _gno. Pt 8 _gp. 2093-103
856	4	0	_uhttps://doi.org/10.1113/jphysiol.2010.203935 _zAvailable from publisher's website
999			_c20753418 _d20753418